Superiority of Intestinal Adaptation by Hepatocyte Growth Factor in the Jejunum: An Experimental Study in a Short-Bowel Rat Model

This experimental study investigates recombinant human hepatocyte growth factor (rh-HGF) as a therapeutic agent to enhance intestinal adaptation in a rat model of short bowel syndrome. The research specifically examines HGF's effects on jejunal tissue, offering potential insights for improving intestinal rehabilitation strategies in SBS patients.